Vigilant Biosciences
Biotechnology, 500 Nw 62nd St Ste 300, Lakeway, Texas, 33309, United States, 11-50 Employees
Phone Number: +18*********
Who is VIGILANT BIOSCIENCES
Vigilant Biosciences is a leading innovator and developer of solutions that aid clinicians in the early detection of cancer. The BeVigilantTM OraFusion System aids clinicians with identif...
Read More
-
Headquarters: 500 Nw 62nd St Ste 300, Lakeway , Texas, 33309, United States
-
Date Founded: 2011
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 3841
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from VIGILANT BIOSCIENCES
Vigilant Biosciences Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Vigilant Biosciences
Answer: Vigilant Biosciences's headquarters are located at 500 Nw 62nd St Ste 300, Lakeway, Texas, 33309, United States
Answer: Vigilant Biosciences's phone number is +18*********
Answer: Vigilant Biosciences's official website is https://vigilantbiosciences.com
Answer: Vigilant Biosciences's revenue is $10 Million to $25 Million
Answer: Vigilant Biosciences's SIC: 3841
Answer: Vigilant Biosciences's NAICS: 541714
Answer: Vigilant Biosciences has 11-50 employees
Answer: Vigilant Biosciences is in Biotechnology
Answer: Vigilant Biosciences contact info: Phone number: +18********* Website: https://vigilantbiosciences.com
Answer: Vigilant Biosciences is a leading innovator and developer of solutions that aid clinicians in the early detection of cancer. The BeVigilantTM OraFusion System aids clinicians with identifying patients at risk for oral cancers. It is simple, accurate and cost-effective, empowering healthcare practitioners to improve lives through earlier intervention. The BeVigilantTM OraFusion System, the first and only technology that measures tumor-initiating and stem cell associated biomarkers markers clinically validated to be associated with oral cancer was developed to aid clinicians in the early detection of oral cancer. The point-of-care BeVigilantTM OraFusion System uses a simple collection method that is easy to administer and non-invasive for the patient. The test has the potential to benefit adults at risk of oral cancer, with particular emphasis on high-risk populations (i.e., current and former tobacco users, those who consume excessive alcohol, and people with human papillomavirus, HPV-16). The BeVigilantTM OraFusion System is CE Marked and available in select markets outside of the United States. The BeVigilantTM OraFusion System is not available for sale in the U.S. Leadership: Bill Brodie, Chief Executive Officer Robert T. Hamilton, CPA, Chief Financial Officer Dragan Nebrigic, Ph.D., Chief Operating Officer Ben Beckham, Chief Commercial Officer Michael Donovan, M.D. Ph.D., Chief Clinical Officer
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month